A detailed history of Black Rock Inc. transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 2,032,155 shares of ACRS stock, worth $5.53 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,032,155
Previous 5,202,147 60.94%
Holding current value
$5.53 Million
Previous $6.45 Million 65.35%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$1.01 - $1.36 $3.2 Million - $4.31 Million
-3,169,992 Reduced 60.94%
2,032,155 $2.24 Million
Q1 2024

May 10, 2024

SELL
$0.92 - $1.44 $647,427 - $1.01 Million
-703,725 Reduced 11.92%
5,202,147 $6.45 Million
Q4 2023

Feb 13, 2024

BUY
$0.64 - $6.49 $190,708 - $1.93 Million
297,982 Added 5.31%
5,905,872 $6.2 Million
Q3 2023

Nov 13, 2023

BUY
$6.56 - $10.95 $89,983 - $150,201
13,717 Added 0.25%
5,607,890 $38.4 Million
Q2 2023

Aug 11, 2023

BUY
$7.89 - $10.64 $3.78 Million - $5.09 Million
478,800 Added 9.36%
5,594,173 $58 Million
Q1 2023

May 12, 2023

BUY
$7.07 - $17.95 $188,867 - $479,516
26,714 Added 0.52%
5,115,373 $41.4 Million
Q4 2022

Feb 13, 2023

BUY
$14.33 - $18.37 $3.99 Million - $5.11 Million
278,361 Added 5.79%
5,088,659 $80.1 Million
Q3 2022

Nov 14, 2022

BUY
$13.07 - $18.22 $1.83 Million - $2.56 Million
140,382 Added 3.01%
4,810,298 $75.7 Million
Q2 2022

Aug 12, 2022

BUY
$10.16 - $17.08 $6.94 Million - $11.7 Million
682,809 Added 17.13%
4,669,916 $65.2 Million
Q1 2022

May 12, 2022

SELL
$9.74 - $17.92 $893,820 - $1.64 Million
-91,768 Reduced 2.25%
3,987,107 $68.7 Million
Q4 2021

Feb 10, 2022

BUY
$12.27 - $18.49 $3.56 Million - $5.37 Million
290,458 Added 7.67%
4,078,875 $59.3 Million
Q3 2021

Nov 09, 2021

BUY
$13.38 - $18.8 $7.35 Million - $10.3 Million
549,368 Added 16.96%
3,788,417 $68.2 Million
Q2 2021

Aug 11, 2021

BUY
$17.08 - $29.6 $55.3 Million - $95.9 Million
3,239,049 New
3,239,049 $56.9 Million

Others Institutions Holding ACRS

About Aclaris Therapeutics, Inc.


  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $181M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.